Glatiramer acetate immunization markedly inhibited Aβ plaques and preserved cognitive function in an AD mouse model through upregulation of OPN, which regulated immunological profiles and physiological functions of macrophages to resist pathogenic factors of AD (Rentsendorj et al., 2018). This evidence concerns the gene SPP1 and Alzheimer disease.